• Bunge Global SA reported third quarter and nine-month earnings, showing sales growth year-over-year, while also completing its share buyback program, repurchasing 26,340,516 shares for US$2.44 billion as of November 5, 2025.
• The combination of higher sales and an extensive buyback program highlights the company’s focus on expanding revenues and returning value to shareholders, despite a recent decrease in quarterly net income.
• We will examine how the recently completed share repurchase program influences Bunge Global’s overall investment thesis and future outlook.

Find companies with promising cash flow potential yet trading below their fair value.

Bunge Global Investment Narrative Recap

To be a Bunge Global shareholder today, you need to believe in the long-term value of global agricultural growth and effective integration of recent acquisitions, especially the transformative Viterra merger. The completion of a US$2.44 billion buyback program adds capital return support, but does not materially shift the immediate focus from synergy capture and integration execution, nor the critical risk of ongoing regulatory and market volatility tied to biofuel policies.

Within recent company updates, the finalized Viterra merger stands out, linking directly to Bunge’s main short-term catalyst of achieving operational synergies and strengthening global supply chains. Successfully unlocking the value anticipated from the combined footprint will be key to meeting growth objectives, particularly as pressures persist in refined oils and merchandising segments.

Yet, contrasting this progress, investors should stay alert to continuing uncertainty around government biofuel mandates and how sudden policy shifts could affect...

Bunge Global's outlook anticipates $56.6 billion in revenue and $1.1 billion in earnings by 2028. This is based on a projected 3.3% annual revenue growth rate, with earnings expected to remain flat at $1.1 billion, showing no change from current levels.

Uncover how Bunge Global's forecasts yield a $103.78 fair value, a 8% upside to its current price.

Exploring Other Perspectives

Simply Wall St Community members estimate Bunge’s fair value from US$79.30 up to US$462.25 across five different analyses. While opinions span widely, the company’s greatest near-term catalyst remains the swift realization of cost and commercial synergies from the Viterra merger.

Explore 5 other fair value estimates on Bunge Global - why the stock might be worth 17% less than the current price!

Build Your Own Bunge Global Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Bunge Global research is our analysis highlighting 4 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Bunge Global research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bunge Global's overall financial health at a glance.

No Opportunity In Bunge Global?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with financially sound penny stocks that balance risk and reward.
• These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.